Does RUXOLITINIB Cause Product physical issue? 302 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 302 reports of Product physical issue have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.4% of all adverse event reports for RUXOLITINIB.
302
Reports of Product physical issue with RUXOLITINIB
0.4%
of all RUXOLITINIB reports
1
Deaths
8
Hospitalizations
How Dangerous Is Product physical issue From RUXOLITINIB?
Of the 302 reports, 1 (0.3%) resulted in death, 8 (2.6%) required hospitalization.
Is Product physical issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 302 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Product physical issue?
SUMATRIPTAN (2,349)
TIOTROPIUM (807)
ICOSAPENT ETHYL (666)
LISDEXAMFETAMINE DIMESYLATE (652)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (387)
IBUPROFEN (337)
ESTRADIOL\LEVONORGESTREL (305)
ESTRADIOL (302)
IXAZOMIB (298)
BUPRENORPHINE (260)
Which RUXOLITINIB Alternatives Have Lower Product physical issue Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE